News & Updates

Patients with de novo human epidermal growth receptor 2 (HER2)-positive metastatic breast cancer (MBC) who show radiographic response to first-line HER2-directed therapy are more likely to achieve long-term survival, suggests a recent study.

Use of either stereotactic body radiotherapy (SBRT) or yttrium-90 (Y90) is effective in the management of hepatocellular carcinoma (HCC), resulting in similar overall and progression-free survival, reports a study. However, Y90 is more expensive than SBRT.

The rates of breast cancer-related lymphedema (BCRL) in Singapore are similar to those across the globe, reports a Singapore study. In addition, the findings also stress the comparable profiles of patients who are vulnerable to the disease.

A weight management intervention results in better body composition, quality of life, and prostate cancer (PCa) biomarkers in men scheduled for prostatectomy, reports a study.